News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

You are here: epigenomics > News & Investors

News & Investors

07. January 2019

Epigenomics AG Announces Positive Results from Microsimulation Model

Read more

20. December 2018

Epigenomics AG Announces Initiation of a Prospective Clinical Study for Liver Cancer Detection

Read more

19. December 2018

Centers for Medicare & Medicaid Services issue official 2019 Clinical Lab Fee Schedule including Epi proColon®

Read more

07. November 2018

Epigenomics AG Announces 2018 Third Quarter and Nine Months Financial Results

Read more

31. October 2018

Epigenomics AG Announces Veterans Administration’s Adherence Study using Epi proColon® Colorectal Cancer Screening Blood Test

Read more

29. October 2018

Epigenomics AG obtains CE Mark for Liquid Biopsy Test for Liver Cancer Detection

Read more